No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:39009600-39016200 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr6:39012200-39017800 |
Weak transcription |
HMEC |
breast
|
3 |
chr6:39015800-39016200 |
Bivalent Enhancer |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
4 |
chr6:39015800-39016200 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
5 |
chr6:39015800-39016200 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
6 |
chr6:39015800-39016200 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
7 |
chr6:39015800-39016200 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
8 |
chr6:39015800-39017400 |
Enhancers |
Fetal Heart |
heart
|
9 |
chr6:39015800-39017600 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
10 |
chr6:39015800-39017600 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
11 |
chr6:39015800-39017600 |
Flanking Bivalent TSS/Enh |
Dnd41 |
blood
|
12 |
chr6:39016000-39016200 |
Flanking Bivalent TSS/Enh |
ES-I3 Cell Line |
embryonic stem cell
|
13 |
chr6:39016000-39016200 |
Flanking Bivalent TSS/Enh |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
14 |
chr6:39016000-39016200 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
15 |
chr6:39016000-39016200 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
16 |
chr6:39016000-39016200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
17 |
chr6:39016000-39016200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
18 |
chr6:39016000-39016200 |
Bivalent Enhancer |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
19 |
chr6:39016000-39016200 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
20 |
chr6:39016000-39016400 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
21 |
chr6:39016000-39016400 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
22 |
chr6:39016000-39016400 |
Flanking Bivalent TSS/Enh |
Breast Myoepithelial Primary Cells |
Breast
|
23 |
chr6:39016000-39016400 |
Flanking Active TSS |
Pancreas |
Pancrea
|
24 |
chr6:39016000-39016400 |
Flanking Bivalent TSS/Enh |
Stomach Smooth Muscle |
stomach
|
25 |
chr6:39016000-39016600 |
Bivalent/Poised TSS |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
26 |
chr6:39016000-39016600 |
Active TSS |
Right Ventricle |
heart
|
27 |
chr6:39016000-39016800 |
Bivalent/Poised TSS |
Primary T cells from cord blood |
blood
|
28 |
chr6:39016000-39016800 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
29 |
chr6:39016000-39017000 |
Bivalent/Poised TSS |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
30 |
chr6:39016000-39017000 |
Flanking Bivalent TSS/Enh |
Brain Germinal Matrix |
brain
|
31 |
chr6:39016000-39017000 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
32 |
chr6:39016000-39017000 |
Enhancers |
Spleen |
Spleen
|
33 |
chr6:39016000-39017200 |
Bivalent/Poised TSS |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
34 |
chr6:39016000-39017400 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
35 |
chr6:39016000-39017600 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
36 |
chr6:39016000-39020000 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|